{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:42:42Z","timestamp":1741754562695,"version":"3.38.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,11]]},"DOI":"10.7759\/cureus.80422","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T20:57:01Z","timestamp":1741726621000},"source":"Crossref","is-referenced-by-count":0,"title":["Area Deprivation Index and Coprescription of Opioids and Sedative Hypnotics"],"prefix":"10.7759","author":[{"given":"Shelby","family":"Goicochea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Bhullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benton J","family":"Stamper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Guerrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Pomm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitty","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Understanding the opioid overdose epidemic. (2021). https.\/\/www.cdc.gov\/opioids\/basics\/epidemic.html."},{"key":"ref2","unstructured":"A look at changes in opioid prescribing patterns in Medicaid from 2016 to 2019. (2023). https.\/\/www.kff.org\/medicaid\/issue-brief\/a-look-at-changes-in-opioid-prescribing-patterns-in-medicaid-from-2016-to-2019."},{"key":"ref3","unstructured":"Wide-ranging online data for epidemiologic research (WONDER). (2022). http.\/\/wonder.cdc.gov."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0665","article-title":"Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017","volume":"2","author":"Schieber LZ","year":"2019","unstructured":"Schieber LZ, Guy GP Jr, Seth P, Young R, Mattson CL, Mikosz CA, Schieber RA. Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017. JAMA Netw Open. 2019, 2:e190665. 10.1001\/jamanetworkopen.2019.0665","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber MA","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. Am J Public Health. 2016, 106:686-688. 10.2105\/AJPH.2016.303061","journal-title":"Am J Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun EC","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017, 356:j760. 10.1136\/bmj.j760","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000828","article-title":"Association between benzodiazepine and opioid prescription and mortality among patients in a large healthcare system","volume":"16","author":"Mooney LJ","year":"2022","unstructured":"Mooney LJ, Zhu Y, Yoo CK, Wolitzky-Taylor K, Hser YI. Association between benzodiazepine and opioid prescription and mortality among patients in a large healthcare system. J Addict Med. 2022, 16:65-71. 10.1097\/ADM.0000000000000828","journal-title":"J Addict Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220312","article-title":"Risk of experiencing an overdose event for patients undergoing treatment with medication for opioid use disorder","volume":"180","author":"Brandt L","year":"2023","unstructured":"Brandt L, Hu MC, Liu Y, et al.. Risk of experiencing an overdose event for patients undergoing treatment with medication for opioid use disorder. Am J Psychiatry. 2023, 180:386-394. 10.1176\/appi.ajp.20220312","journal-title":"Am J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003709","article-title":"Mortality and concurrent use of opioids and hypnotics in older patients: a retrospective cohort study","volume":"18","author":"Ray WA","year":"2021","unstructured":"Ray WA, Chung CP, Murray KT, Malow BA, Daugherty JR, Stein CM. Mortality and concurrent use of opioids and hypnotics in older patients: a retrospective cohort study. PLoS Med. 2021, 18:e1003709. 10.1371\/journal.pmed.1003709","journal-title":"PLoS Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05545-y","article-title":"Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: a retrospective cohort study","volume":"35","author":"Cho J","year":"2020","unstructured":"Cho J, Spence MM, Niu F, Hui RL, Gray P, Steinberg S. Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: a retrospective cohort study. J Gen Intern Med. 2020, 35:696-703. 10.1007\/s11606-019-05545-y","journal-title":"J Gen Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal SD","year":"2019","unstructured":"Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open. 2019, 2:e187399. 10.1001\/jamanetworkopen.2018.7399","journal-title":"JAMA Netw Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2361","article-title":"Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999-2017","volume":"3","author":"Tori ME","year":"2020","unstructured":"Tori ME, Larochelle MR, Naimi TS. Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999-2017. JAMA Netw Open. 2020, 3:e202361. 10.1001\/jamanetworkopen.2020.2361","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20071038","article-title":"The risk of overdose with concomitant use of Z-drugs and prescription opioids: a population-based cohort study","volume":"178","author":"Szmulewicz A","year":"2021","unstructured":"Szmulewicz A, Bateman BT, Levin R, Huybrechts KF. The risk of overdose with concomitant use of Z-drugs and prescription opioids: a population-based cohort study. Am J Psychiatry. 2021, 178:643-650. 10.1176\/appi.ajp.2020.20071038","journal-title":"Am J Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H473","article-title":"Healthcare outcomes associated with beers' criteria: a systematic review","volume":"41","author":"Jano E","year":"2007","unstructured":"Jano E, Aparasu RR. Healthcare outcomes associated with beers' criteria: a systematic review. Ann Pharmacother. 2007, 41:438-447. 10.1345\/aph.1H473","journal-title":"Ann Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057588","article-title":"Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings","volume":"12","author":"Suvada K","year":"2022","unstructured":"Suvada K, Zimmer A, Soodalter J, Malik JS, Kavalieratos D, Ali MK. Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings. BMJ Open. 2022, 12:e057588. 10.1136\/bmjopen-2021-057588","journal-title":"BMJ Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gly283","article-title":"Coprescribing of benzodiazepines and opioids in older adults: rates, correlates, and national trends","volume":"74","author":"Rhee TG","year":"2019","unstructured":"Rhee TG. Coprescribing of benzodiazepines and opioids in older adults: rates, correlates, and national trends. J Gerontol A Biol Sci Med Sci. 2019, 74:1910-1915. 10.1093\/gerona\/gly283","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6845a2","article-title":"Tobacco product use and cessation indicators among adults - United States, 2018","volume":"68","author":"Creamer MR","year":"2019","unstructured":"Creamer MR, Wang TW, Babb S, et al.. Tobacco product use and cessation indicators among adults - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019, 68:1013-1019. 10.15585\/mmwr.mm6845a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.0052","article-title":"Association of primary care visit length with potentially inappropriate prescribing","volume":"4","author":"Neprash HT","year":"2023","unstructured":"Neprash HT, Mulcahy JF, Cross DA, Gaugler JE, Golberstein E, Ganguli I. Association of primary care visit length with potentially inappropriate prescribing. JAMA Health Forum. 2023, 4:e230052. 10.1001\/jamahealthforum.2023.0052","journal-title":"JAMA Health Forum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.28557","article-title":"Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015","volume":"3","author":"Xu KY","year":"2020","unstructured":"Xu KY, Hartz SM, Borodovsky JT, Bierut LJ, Grucza RA. Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015. JAMA Netw Open. 2020, 3:e2028557. 10.1001\/jamanetworkopen.2020.28557","journal-title":"JAMA Netw Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/21501319221147378","article-title":"Sedative-hypnotic co-prescribing with opioids in a large network of community health centers","volume":"14","author":"Hartung DM","year":"2023","unstructured":"Hartung DM, Lucas JA, Huguet N, et al.. Sedative-hypnotic co-prescribing with opioids in a large network of community health centers. J Prim Care Community Health. 2023, 14:21501319221147378. 10.1177\/21501319221147378","journal-title":"J Prim Care Community Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.11710","article-title":"Averting alert fatigue to prevent adverse drug reactions","volume":"322","author":"Carroll AE","year":"2019","unstructured":"Carroll AE. Averting alert fatigue to prevent adverse drug reactions. JAMA. 2019, 322:601. 10.1001\/jama.2019.11710","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.11590","article-title":"Comparison of prescribing patterns before and after implementation of a national policy to reduce inappropriate alprazolam prescribing in Australia","volume":"2","author":"Schaffer AL","year":"2019","unstructured":"Schaffer AL, Buckley NA, Cairns R, Pearson S. Comparison of prescribing patterns before and after implementation of a national policy to reduce inappropriate alprazolam prescribing in Australia. JAMA Netw Open. 2019, 2:e1911590. 10.1001\/jamanetworkopen.2019.11590","journal-title":"JAMA Netw Open"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109759","article-title":"Mandatory prescription drug monitoring programs and overlapping prescriptions of opioids and benzodiazepines: evidence from Kentucky","volume":"243","author":"Nguyen T","year":"2023","unstructured":"Nguyen T, Meille G, Buchmueller T. Mandatory prescription drug monitoring programs and overlapping prescriptions of opioids and benzodiazepines: evidence from Kentucky. Drug Alcohol Depend. 2023, 243:109759. 10.1016\/j.drugalcdep.2022.109759","journal-title":"Drug Alcohol Depend"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2946","article-title":"Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study","volume":"161","author":"Kind AJ","year":"2014","unstructured":"Kind AJ, Jencks S, Brock J, et al.. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014, 161:765-774. 10.7326\/M13-2946","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/1062860617753063","article-title":"Area deprivation index predicts readmission risk at an urban teaching hospital","volume":"33","author":"Hu J","year":"2018","unstructured":"Hu J, Kind AJ, Nerenz D. Area deprivation index predicts readmission risk at an urban teaching hospital. Am J Med Qual. 2018, 33:493-501. 10.1177\/1062860617753063","journal-title":"Am J Med Qual"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible - the neighborhood atlas","volume":"378","author":"Kind AJ","year":"2018","unstructured":"Kind AJ, Buckingham WR. Making neighborhood-disadvantage metrics accessible - the neighborhood atlas. N Engl J Med. 2018, 378:2456-2458. 10.1056\/NEJMp1802313","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09527-2","article-title":"Correction to: neighborhood socioeconomic disadvantage is associated with multimorbidity in a geographically-defined community","volume":"20","author":"Chamberlain AM","year":"2020","unstructured":"Chamberlain AM, Finney Rutten LJ, Wilson PM, et al.. Correction to: neighborhood socioeconomic disadvantage is associated with multimorbidity in a geographically-defined community. BMC Public Health. 2020, 20:1412. 10.1186\/s12889-020-09527-2","journal-title":"BMC Public Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035376","article-title":"Place, poverty and prescriptions: a cross-sectional study using Area Deprivation Index to assess opioid use and drug-poisoning mortality in the USA from 2012 to 2017","volume":"10","author":"Kurani S","year":"2020","unstructured":"Kurani S, McCoy RG, Inselman J, et al.. Place, poverty and prescriptions: a cross-sectional study using Area Deprivation Index to assess opioid use and drug-poisoning mortality in the USA from 2012 to 2017. BMJ Open. 2020, 10:e035376. 10.1136\/bmjopen-2019-035376","journal-title":"BMJ Open"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18165","article-title":"The association between socioeconomic status and use of potentially inappropriate medications in older adults","volume":"71","author":"Hwang J","year":"2023","unstructured":"Hwang J, Lyu B, Ballew S, et al.. The association between socioeconomic status and use of potentially inappropriate medications in older adults. J Am Geriatr Soc. 2023, 71:1156-1166. 10.1111\/jgs.18165","journal-title":"J Am Geriatr Soc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18288","article-title":"Patterns and disparities in prescribing of opioids and benzodiazepines for older adults in North Carolina","volume":"71","author":"Niznik JD","year":"2023","unstructured":"Niznik JD, Hughes T, Armistead LT, Kashyap J, Roller J, Busby-Whitehead J, Ferreri SP. Patterns and disparities in prescribing of opioids and benzodiazepines for older adults in North Carolina. J Am Geriatr Soc. 2023, 71:1944-1951. 10.1111\/jgs.18288","journal-title":"J Am Geriatr Soc"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8325","article-title":"Rates of physician coprescribing of opioids and benzodiazepines after the release of the Centers for Disease Control and Prevention Guidelines in 2016","volume":"2","author":"Jeffery MM","year":"2019","unstructured":"Jeffery MM, Hooten WM, Jena AB, Ross JS, Shah ND, Karaca-Mandic P. Rates of physician coprescribing of opioids and benzodiazepines after the release of the Centers for Disease Control and Prevention Guidelines in 2016. JAMA Netw Open. 2019, 2:e198325. 10.1001\/jamanetworkopen.2019.8325","journal-title":"JAMA Netw Open"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109176","article-title":"Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States","volume":"229","author":"de Dios C","year":"2021","unstructured":"de Dios C, Fernandes BS, Whalen K, Bandewar S, Suchting R, Weaver MF, Selvaraj S. Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2021, 229:109176. 10.1016\/j.drugalcdep.2021.109176","journal-title":"Drug Alcohol Depend"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.31012","article-title":"Trends in the use of benzodiazepines, Z-hypnotics, and serotonergic drugs among US women and men before and during the COVID-19 pandemic","volume":"4","author":"Milani SA","year":"2021","unstructured":"Milani SA, Raji MA, Chen L, Kuo YF. Trends in the use of benzodiazepines, Z-hypnotics, and serotonergic drugs among US women and men before and during the COVID-19 pandemic. JAMA Netw Open. 2021, 4:e2131012. 10.1001\/jamanetworkopen.2021.31012","journal-title":"JAMA Netw Open"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.10269","article-title":"Multidimensional approach to exploring neighborhood determinants and symptom severity among individuals with psychosis","volume":"7","author":"Oluwoye O","year":"2024","unstructured":"Oluwoye O, Puzia M, Lissau A, Amram O, Weeks DL. Multidimensional approach to exploring neighborhood determinants and symptom severity among individuals with psychosis. JAMA Netw Open. 2024, 7:e2410269. 10.1001\/jamanetworkopen.2024.10269","journal-title":"JAMA Netw Open"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S477128","article-title":"Racial disparities in opioid prescribing in the United States from 2011 to 2021: a systematic review and meta-analysis","volume":"17","author":"Hirani S","year":"2024","unstructured":"Hirani S, Benkli B, Odonkor CA, et al.. Racial disparities in opioid prescribing in the United States from 2011 to 2021: a systematic review and meta-analysis. J Pain Res. 2024, 17:3639-3649. 10.2147\/JPR.S477128","journal-title":"J Pain Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt J","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017, 17:493-507. 10.1007\/s40268-017-0207-7","journal-title":"Drugs R D"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa054","article-title":"Co-prescribing of opioids with benzodiazepines and other hypnotics for chronic pain and insomnia: trends and health outcomes","volume":"21","author":"Koffel E","year":"2020","unstructured":"Koffel E, DeRonne B, Hawkins EJ. Co-prescribing of opioids with benzodiazepines and other hypnotics for chronic pain and insomnia: trends and health outcomes. Pain Med. 2020, 21:2055-2059. 10.1093\/pm\/pnaa054","journal-title":"Pain Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.13063\/2327-9214.1238","article-title":"Introduction of an area deprivation index measuring patient socioeconomic status in an integrated health system: implications for population health","volume":"4","author":"Knighton AJ","year":"2016","unstructured":"Knighton AJ, Savitz L, Belnap T, Stephenson B, VanDerslice J. Introduction of an area deprivation index measuring patient socioeconomic status in an integrated health system: implications for population health. EGEMS (Wash DC). 2016, 4:1238. 10.13063\/2327-9214.1238","journal-title":"EGEMS (Wash DC)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020466","article-title":"Area deprivation index and cardiac readmissions: evaluating risk-prediction in an electronic health record","volume":"10","author":"Johnson AE","year":"2021","unstructured":"Johnson AE, Zhu J, Garrard W, Thoma FW, Mulukutla S, Kershaw KN, Magnani JW. Area deprivation index and cardiac readmissions: evaluating risk-prediction in an electronic health record. J Am Heart Assoc. 2021, 10:e020466. 10.1161\/JAHA.120.020466","journal-title":"J Am Heart Assoc"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1377\/forefront.20241216.487887","article-title":"Enhancing design and implementation of ACO REACH\u2019s equity-focused and beneficiary engagement design elements","volume":"17","author":"Bonesteel R","year":"2024","unstructured":"Bonesteel R, Debab S, Bleser WK, McStay F, Saunders RS. Enhancing design and implementation of ACO REACH\u2019s equity-focused and beneficiary engagement design elements. Health Aff. 2024, 17:10.1377\/forefront.20241216.487887","journal-title":"Health Aff"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336514-area-deprivation-index-and-coprescription-of-opioids-and-sedative-hypnotics","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T20:57:04Z","timestamp":1741726624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336514-area-deprivation-index-and-coprescription-of-opioids-and-sedative-hypnotics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.80422","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}